The economic impact and cost-effectiveness of urinary neutrophil gelatinase-associated lipocalin after cardiac surgery

Clinical Therapeutics

Volumn 33, Issue 11, 2011, Pages 1713-1725

  Shaw, Andrew D ^a   Chalfin, Donald B ^b   Kleintjens, Joris ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b ABBOTT LABORATORIES   (United States)

^c IQVIA   (United States)

Author keywords

Acute kidney injury (AKI); Cardiac surgery; Cost effectiveness; NGAL

Indexed keywords

NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CASE REPORT; CORONARY ARTERY BYPASS SURGERY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; HEART SURGERY; HUMAN; MALE; SENSITIVITY ANALYSIS; URINALYSIS;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; AGED; BIOLOGICAL MARKERS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; LIFE EXPECTANCY; LIPOCALINS; MALE; PROTO-ONCOGENE PROTEINS; SENSITIVITY AND SPECIFICITY; THORACIC SURGICAL PROCEDURES;

EID: 82855179438     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2011.09.014     Document Type: Article

References (38)

1. Loef B.G., Epema A.H., Smilde T.D., et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol 2005, 16:195-200.
2. Haase M., Bellomo R., Devarjan P., et al. Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults. Ann Thorac Surg 2009, 88:124-130.
3. Hoste E.A., Clermont G., Kersten A., et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006, 10:R73-R82.
4. Dasta J.F., Kane-Gill S.L., Durtschi A.J., et al. Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant 2008, 23:1970-1974.
5. Korkeila M., Ruokonen E., Takala J. Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care. Intensive Care Med 2000, 26:1824-1831.
6. Chertow G.M., Burdick E., Honour M., et al. Acute kidney injury, mortality, lengths of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005, 16:3365-3370.
7. Kellum J.A., Bellomo R., Ronco C. Definition and classification of acute kidney injury. Nephron Clin Pract 2008, 109:c182-c187.
8. Devarajan P. Emerging urinary biomarkers in the diagnosis of acute kidney injury. Expert Opin Med Diagn 2008, 2:387-398.
9. Nguyen M.T., Devarajan P. Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol 2008, 23:2151-2157.
10. Edelstein C.L. Biomarkers of acute kidney injury. Adv Chronic Kidney Dis 2008, 15:222-234.
11. Demirkilic U., Kuralay E., Yenicesu M., et al. Timing of replacement therapy for acute renal failure after cardiac surgery. J Card Surg 2004, 19:17-20.
12. Wagener G., Jan M., Kim M., et al. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 2006, 105:485-491.
13. Tuladhar S.M., Puntmann V.O., Soni M., et al. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass. J Cardiovasc Pharmacol 2009, 53:261-266.
14. Koyner J.L., Bennett M.R., Worcester E.M., et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int 2008, 74:1059-1069.
15. Wagener G., Gubitosa G., Wang S., et al. Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery. Am J Kidney Dis 2008, 52:425-433.
16. Gold M.R., Siegel J.E., Russell L.B., Weinstein M.C. Cost-Effectiveness in Health and Medicine 1996, Oxford Press, New York, NY.
17. Mehta R.H., Grab J.D., O'Brien S.M., et al. Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation 2006, 114:2208-2216.
18. National Institute For Health And Clinical Excellence, Single technology appraisal (STA), Specification for manufacturer/sponsor submission of evidence October 2009, Accessed October 27, 2011. http://www.nice.org.uk/aboutnice/howwework/devnicetech/singletechnologyappraisalsubmissiontemplates.jsp?domedia=1&mid=4D9D8C83-19B9-E0B5-D4B0E148B3FE727F.
19. Haase M., Haase-Fielitz A., Bellomo R., et al. Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med 2009, 37:39-47.
20. Go A.S., Chertow G.M., Fan D., et al. Chronic kidney disease and risks of death, cardiovascular events and hospitalization [published correction appears in N Engl J Med. 2008;18:4]. N Engl J Med 2004, 351:1296-1305.
21. 2008, Personal Social Services Research Unit, UK.
22. Klebe B., Irving J., Stevens P.E., et al. The cost of implementing UK guidelines for the management of chronic kidney disease. Nephrol Dial Transplant 2007, 22:2504-2512.
23. Price D., Berg J., Lindgren P. An economic evaluation of NIOX MINO airway inflammation monitor in the United Kingdom. Allergy 2009, 64:431-438.
24. Kievit W., deBruin J.H., Adang E.M., et al. Cost-effectiveness of a new strategy to identify HNPCC patients. Gut 2005, 54:97-102.
25. Mushlin A.I., Mooney C., Holloway R.G., et al. The cost-effectiveness of magnetic resonance imaging for patients with equivocal neurological symptoms. Int J Technol Assess Health Care 1997, 13:21-34.
26. Durmaz I., Yagdi T., Calkavur T., et al. Prophylactic dialysis in patients with renal dysfunction undergoing on-pump coronary artery bypass surgery. Ann Thorac Surg 2003, 75:859-864.
27. Callahan M., Battelman D.S., Christos P., et al. Economic consequences of renal dysfunction among cardiopulmonary bypass surgery patients: a hospital-based perspective. Value Health 2003, 6:137-143.
28. Berkowitz R., Ugwu O.C., Dhruva V., et al. Reduction in length of stay of heart failure admissions using B-type natriuretic peptide assay in the emergency department to facilitate early identification. J Cardiac Failure 2003, 9:S105.
29. Cooke C.R., Kahn J.M., Watkins T.R., et al. Cost-effectiveness of implementing low-tidal volume ventilation in patients with acute lung injury. Chest 2009, 136:79-88.
30. Rankin J.S., Hammill B.G., Ferguson T.B., et al. Determinants of operative mortality in heart surgery. Journal of Thoracic and Cardiovascular Surgery 2006, 131:547-557.
31. Vogt A., Grube E., Glunz H.G., et al. Determinants of mortality after cardiac surgery: results of the Registry of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK) on 10, 525 patients. Eur Heart J 2000, 21:28-32.
32. Aviram G., Mohr R., Sharony R., et al. Open heart reoperations after coronary artery bypass grafting: the role of preoperative imaging with multidetector computed tomography. Isr Med Assoc J 2009, 11:465-469.
33. Weinstein M.C., O'Brien B., Hornberger J., et al. Principles of good practice for decision analytic modelling in health-care evaluation: report of the ISPOR Task Force on good research practices-modelling studies. Value Health 2003, 6:9017.
34. Patel M.R., Dehmer G.J., Hirshfeld J.W. ACCF/SCAI/AATS/AHA/ASNC 2009 Appropriateness criteria for coronary revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology. Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2009, 10:530-533.
35. Zelmer J.L. The economic burden of end-stage renal disease in Canada. Kidney Int 2007, 72:1122-1129.
36. Sullivan S. Employer challenges with the chronic kidney disease population. J Manag Care Pharm 2007, 13:S19-S21.
37. Rice D.P. Cost of illness studies: what is good about them?. Inj Prev 2000, 6:177-179.
38. Drummond M., Sculpher M.J., Torrance G.W., et al. Methods for Economic Evaluation of Health Care Programs 2005, Oxford University Press, Oxford. 3rd ed.